Dawn Carter Bir, Chief Commercial Officer at REATA PHARMACEUTICALS INC (RETA), sold 40,000 shares at $164.54 ($6.6M) on 2023-07-28, disclosed to the SEC on 2023-08-01.
Scheduled sale ($6.6M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | SELL | 2023-03-15 | $1.6M | — | Filing → |
| RETA | SELL | 2023-03-08 | $17.0M | — | Filing → |
| RETA | SELL | 2023-03-06 | $382K | — | Filing → |